Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NEPH

NEPH - Nephros Inc Stock Price, Fair Value and News

$4.56+0.13 (+2.93%)
Market Closed

63/100

NEPH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

63/100

NEPH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$5.26

Target 3M

$4.82

Target 6M

$4.97

NEPH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NEPH Price Action

Last 30 days

-6.4%

Last 90 days

-18.7%

Trailing 12 Months

169.8%

NEPH RSI Chart

NEPH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NEPH Valuation

Market Cap

48.5M

Price/Earnings (Trailing)

32.72

Price/Sales (Trailing)

2.7

EV/EBITDA

39.39

Price/Free Cashflow

17.82

NEPH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$5.26

Target 3M

$4.82

Target 6M

$4.97

NEPH Fundamentals

NEPH Revenue

Revenue (TTM)

17.9M

Rev. Growth (Yr)

35.42%

Rev. Growth (Qtr)

7.81%

NEPH Earnings

Earnings (TTM)

1.5M

Earnings Growth (Yr)

84.15%

Earnings Growth (Qtr)

42.19%

NEPH Profitability

EBT Margin

6.32%

Return on Equity

14.8%

Return on Assets

11.18%

Free Cashflow Yield

5.61%

NEPH Investor Care

Shares Dilution (1Y)

0.78%

Diluted EPS (TTM)

0.14

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202515.5M16.7M17.9M0
202414.1M13.8M13.5M14.2M
202311.5M12.2M13.5M14.2M
20229.7M10.3M10.2M10.0M
20218.8M9.5M9.9M10.3M
20207.2M7.4M7.8M8.6M
20184.1M4.6M5.4M5.7M
20172.5M2.8M3.3M3.8M
20162.0M1.9M2.1M2.3M
20151.8M1.9M1.8M1.9M
20141.7M1.6M1.6M1.7M
20131.8M2.1M1.9M1.7M
20122.1M1.7M1.9M1.8M
20112.6M2.5M2.2M2.2M
201002.8M2.8M2.9M
20090002.7M
Get all data in R, Python etc through our Historical Stock Data APIs

About Nephros Inc

NEPH
Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
 CEO
 WEBSITEnephros.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES27

Nephros Inc Frequently Asked Questions

NEPH is the stock ticker symbol of Nephros Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Nephros Inc is 48.46 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NEPH's fair value in chart for subscribers.

The fair value guage provides a quick view whether NEPH is over valued or under valued. Whether Nephros Inc is cheap or expensive depends on the assumptions which impact Nephros Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NEPH.

As of Wed Jan 28 2026, NEPH's PE ratio (Price to Earnings) is 32.72 and Price to Sales (PS) ratio is 2.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NEPH PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Nephros Inc has provided 0.038 (multiply by 100 for percentage) rate of return.